If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
IPO today
Twelve Seas Investment Company (TWLVU)
Kensington Capital Acquisition (KCAC.U)
African Gold Acquisition (AGAC.U)
Fusion Acquisition II (FSNB.U)
Mcap Acquisition (MACQU)
Silverbox Engaged Merger I (SBEAU)
Ibere Pharmaceuticals (IBERU)
Freedom Acquisition I (FACT.U)
Arya Sciences Acquisition IV (ARYD)
Warrior Technologies Acquisition Company (WARR.U)
Austerlitz Acquisition Corporation II (ASZ.U)
Austerlitz Acquisition Corporation I (AUS.U)
Leo Holdings III Corp. (LIII.U)
Upcoming IPO
Property Solutions Acquisition II (PSAGU)
Nightdragon Acquisition (NDACU)
Roblox Corporation (RBLX)
Afc Gamma, Inc. (AFCG)
Roth Ch Acquisition III (ROCRU)
Oscar Health, Inc. (OSCR)
Innovage Holding Corp (INNV)
Priced IPO
Score Media And Gaming, Inc. (SCR)
Briacell Therapeutics Corp. (BCTX)
Clip Interactive, LLC (AUDD)
Greenbox Pos (GBOX)
Virpax Pharmaceuticals, Inc. (VRPX)
Urban-gro (UGRO)
Neximmune, Inc. (NEXI)
Longeveron (LGVN)
Talis Biomedical Corporation (TLIS)
Decibel Therapeutics, Inc. (DBTX)
Loandepot, Inc. (LDI)
Bumble, Inc. (BMBL)
Apria, Inc. (APR)
Signify Health, Inc.. (SGFY)
Bioventus Inc. (BVS)
Biophytis SA (BPTS)
Vallon Pharmaceuticals (VLON)
Viant Technology Inc. (DSP)
Global Internet of People (SDH)
Baosheng Media Group Holdings (BAOS)
More companies

Bioventus Inc. (BVS)

Sector - Healthcare

Price chart

Return from IPO

Company News

IPO Profile

About company

They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process. These products address an estimated $6 billion market opportunity across osteoarthritic (OA) joint pain treatment and joint preservation, spinal fusion surgery and bone fractures, each of which is experiencing growth through multiple industry tailwinds. Their devices are most often used to delay or replace the need for an elective surgical procedure and are focused on reaching patients early on in their treatment paradigm. In 2019, approximately 85% of their $340.1 million in revenues were derived from products associated with non-surgical procedures. Their products are widely reimbursed by both public and private health insurers and are sold in the physician’s office or clinic, ambulatory surgical centers, and the hospital setting in the US and across 37 countries. They have broad commercial reach across their established orthopedic customer base, which they are focused on leveraging to continue to grow the company by expanding their market share and product portfolio. This strategy has led to a 7.4% CAGR in revenue since 2016 and during this time period, their revenue has grown from $274.5 million to $340.1 million in 2019.
Surgical & Medical Instruments & Apparatus
Kenneth M. Reali Gregory O. Anglum
Employees Founded
680 2011


Address: 4721 Emperor Boulevard, Suite 100 Durham, North Carolina 27703

Telephone: (919) 474-6700

Web page:

IPO information

Expected Date 2/11/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
Share prices ($)

Shares & Volumes

Shares Initial (MM) 7.35
Shares Revised (MM) 8
Expected offer amount (MM) $124.95
Realized offer amount(MM) $104

Financial Data (last reporting year)

Market Cap (MM) $921.91
Revenues (MM) $320.12
Net Income (Loss) (MM) $17.78


What do you think will happen with the BVS share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Morgan Stanley

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Morgan Stanley/ JP Morgan/ Goldman Sachs
Canaccord Genuity

Sector: Healthcare

Tweets about $BVS

Tweets volume:

RT volume:


Google Trends Stats